Atea Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 104K | 0 | 38.2M | 2.4M | 3.4M | 104K | 19.9M | 104K |
| Gross Profit | -104K | 0 | -38.2M | -2.4M | -3.4M | -104K | -19.9M | -104K |
| R&D Expenses | 41.1M | 47.8M | 38.3M | 32.3M | 29.6M | 25.7M | 26.2M | 34.7M |
| Operating Expenses | 47.9M | 54.9M | 7.3M | 38.9M | 35.6M | 38.9M | 17.3M | 46.8M |
| Operating Income | -48.0M | -54.9M | -45.6M | -41.3M | -39.0M | -39.0M | -37.2M | -46.9M |
| Other Income / Gains | 2.6M | 3.3M | 3.7M | 4.4M | 5.0M | 5.7M | 6.3M | 6.6M |
| Net Income | -45.4M | -44.9M | -42.0M | -37.2M | -34.3M | -33.5M | -31.2M | -40.5M |
| EPS (Diluted) | -0.57 | -0.57 | -0.53 | -0.44 | -0.40 | -0.40 | -0.37 | -0.48 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 6.9M | 7.1M | 7.2M | 9.1M | 9.5M | 0 | 11.0M | 12.2M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -104K |
| Selling General And Administrative Expenses | 6.9M | 7.1M | 7.2M | 9.1M | 9.5M | 13.3M | 11.0M | 12.1M |
| Other Expenses | -104K | 0 | -38.2M | -2.4M | -3.4M | 0 | -19.9M | 0 |
| Cost And Expenses | 48.0M | 54.9M | 45.6M | 41.3M | 39.0M | 39.0M | 37.2M | 46.9M |
| Interest Income | 2.6M | 3.3M | 3.7M | 4.4M | 5.0M | 5.7M | 6.3M | 6.6M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K |
| Ebitda | -45.3M | -51.5M | -41.7M | -41.3M | -34.0M | -33.2M | -30.9M | -40.2M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -45.4M | -51.6M | -41.9M | -37.0M | -34.1M | -33.3M | -30.9M | -40.3M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 50K | -6.8M | 196K | 207K | 203K | 225K | 226K | 243K |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.57 | -0.57 | -0.53 | -0.44 | -0.40 | -0.40 | -0.37 | -0.48 |
| Weighted Average Shs Out | 79.2M | 78.1M | 79.1M | 83.7M | 85.2M | 84.5M | 84.4M | 84.3M |
| Weighted Average Shs Out Dil | 79.2M | 78.1M | 79.1M | 83.7M | 85.2M | 84.5M | 84.4M | 84.3M |